Moderna Inc MRNA
News
7 healthcare stocks that stand out as -2-
Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data.
Moderna to Report Third Quarter 2026 Financial Results on Friday, November 6, 2026
Flu season is already here. Here's what to know about this year's flu shots.
Tempus Enters Multiyear Collaboration With Moderna, Merck Aimed at Commercializing Cancer Drug
Citi tells investors it's time to sell Moderna after 600%-plus stock gains
Moderna Adds Chief Operating Officer Role as Company Expands into Oncology
Moderna will reveal the data for its mRNA cancer vaccine next month. Here's why it matters.
Moderna Announces Late-Breaking Data to be Presented at ESMO Congress 2026
AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033
Moderna to Present at Upcoming Conferences in September 2026
23 best-performing stocks of August, as the software industry continues its recovery
23 best-performing stocks of August, as the -2-
FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech, Novavax — Update
Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes
FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech
Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines
Moderna to Sell $2 Billion Convertible Notes in Private Placement
Moderna Announces Proposed Private Placement of $2.0 Billion of Convertible Senior Notes


